817
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Effects of Apelin on the fibrosis of retinal tissues and Müller cells in diabetes retinopathy through the JAK2/STAT3 signalling pathway

, &
Article: 2259129 | Received 11 Apr 2023, Accepted 10 Sep 2023, Published online: 28 Sep 2023

References

  • Singh PK, Tandon R. Correlation study of apolipoprotein’a’ with diabetic retinopathy in patients of type 2 diabetes mellitus with retinopathy. J Assoc Physicians India. 2020;68:1.
  • Yin L, Zhang D, Ren Q, et al. Prevalence and risk factors of diabetic retinopathy in diabetic patients: a community based cross-sectional study. Medicine (Baltimore). 2020;99(9):e19236.
  • Alasil T, Waheed NK. Pan retinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser. Curr Opin Ophthalmol. 2014;25(3):164–10.
  • Kempegowda P, Sunsoa H, Chandan JS, et al. Retinopathy and microalbuminuria are common microvascular complications in cystic fibrosis-related diabetes. Ther Adv Endocrinol. 2020;11:1905080292.
  • Parola M, Pinzani M. Pathophysiology of organ and tissue fibrosis. Mol Aspects Med. 2019;65:1.
  • Coughlin BA, Feenstra DJ, Mohr S. Muller cells and diabetic retinopathy. Vision Res. 2017;139:93–100.
  • Goldman D. Müller glial cell reprogramming and retina regeneration. Nat Rev Neurosci. 2014;15(7):431–442.
  • Eastlake K, Lamb W, Luis J, et al. Prospects for the application of Muller glia and their derivatives in retinal regenerative therapies. Prog Retin Eye Res. 2021;85:100970.
  • Fan J, Shen W, Lee SR, et al. Targeting the Notch and TGF-beta signaling pathways to prevent retinal fibrosis in vitro and in vivo. Theranostics. 2020;10(18):7956–7973.
  • Lei X, Zhang J, Shen J, et al. EPO attenuates inflammatory cytokines by muller cells in diabetic retinopathy. Frontiers Biosci. 2011;3:201. (Elite edition)
  • Rezzola S, Guerra J, Krishna CA, et al. VEGF-Independent activation of muller cells by the vitreous from proliferative diabetic retinopathy patients. Int J Mol Sci. 2021;22(4):2179.
  • Antushevich H, Wójcik M. Review: apelin in disease. Clin Chim Acta. 2018;483:241–248.
  • Castan-Laurell I, Dray C, Valet P. The therapeutic potentials of apelin in obesity-associated diseases. Mol Cell Endocrinol. 2021;529:111278.
  • Chen L, Zhou T, White T, et al. The Apelin-Apelin receptor axis triggers cholangiocyte proliferation and liver fibrosis during mouse models of cholestasis. Hepatology. 2021;73(6):2411–2428.
  • Yan J, Wang A, Cao J, et al. Apelin/APJ system: an emerging therapeutic target for respiratory diseases. Cell Mol Life Sci. 2020;77(15):2919–2930.
  • Chen W, Oue T, Ueno T, et al. Apelin is a marker of the progression of liver fibrosis and portal hypertension in patients with biliary atresia. Pediatr Surg Int. 2013;29(1):79–85.
  • Falcao-Pires I, Goncalves N, Henriques-Coelho T, et al. Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol. 2009;296(6):H2007–H2014.
  • Yang W, Zhang S, Zhu J, et al. Gut microbe-derived metabolite trimethylamine N-oxide accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis. J Mol Cell Cardiol. 2019;134:119–130.
  • Kimura T, Monslow J, Klampatsa A, et al. Loss of cells expressing fibroblast activation protein has variable effects in models of TGF-β and chronic bleomycin-induced fibrosis. Am J Physiol Lung Cell Mol Physiol. 2019;317(2):L271–L282.
  • Devoldere J, Peynshaert K, De Smedt SC, et al. Müller cells as a target for retinal therapy. Drug Discov Today. 2019;24(8):1483–1498.
  • Roy S, Amin S, Roy S. Retinal fibrosis in diabetic retinopathy. Exp Eye Res. 2016;142:71–75.
  • Graca AB, Hippert C, Pearson RA. Muller glia reactivity and development of gliosis in response to pathological conditions. Adv Exp Med Biol. 2018;1074:303–308.
  • Habata Y, Fujii R, Hosoya M, et al. Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochim Biophys Acta. 1999;1452(1):25–35.
  • Liu Q, Jiang J, Shi Y, et al. Apelin/apelin receptor: a new therapeutic target in polycystic ovary syndrome. Life Sci. 2020;260:118310.
  • Zhou JX, Shuai NN, Wang B, et al. Neuroprotective gain of apelin/APJ system. NEUROPEPTIDES. 2021;87:102131.
  • Cheng J, Luo X, Huang Z, et al. Apelin/APJ system: a potential therapeutic target for endothelial dysfunction-related diseases. J Cell Physiol. 2019;234(8):12149–12160.
  • Huang S, Chen L, Lu L, et al. The apelin–APJ axis: a novel potential therapeutic target for organ fibrosis. Clin Chim Acta. 2016;456:81–88.
  • Wang Y, Song J, Bian H, et al. Apelin promotes hepatic fibrosis through ERK signaling in LX-2 cells. Mol Cell Biochem. 2019;460(1-2):205–215.
  • Lv W, Zhang L, Cheng X, et al. Apelin inhibits angiotensin II-Induced atrial fibrosis and atrial fibrillation via TGF-β1/Smad2/α-SMA pathway. Front Physiol. 2020;11:583570.
  • Qin Y, Zhao P, Chen Y, et al. Lipopolysaccharide induces epithelial–mesenchymal transition of alveolar epithelial cells cocultured with macrophages possibly via the JAK2/STAT3 signaling pathway. Hum Exp Toxicol. 2020;39(2):224–234.
  • Hui J, Gao J, Wang Y, et al. Panax notoginseng saponins ameliorates experimental hepatic fibrosis and hepatic stellate cell proliferation by inhibiting the Jak2/Stat3 pathways. J Tradit Chin Med, 2 2016;36:217–224
  • Zhang Y, Dees C, Beyer C, et al. Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis. Ann Rheum Dis. 2015;74(5):936–943.